Viral safety is a key issue for biological and biotechnological medicinal products. This first joint PDA/EMEA European Virus Safety Forum brought together a panel of speakers to discuss knowledge and regulatory aspects in the areas of virus safety of recombinant proteins, monoclonal antibodies, plasma-derived medicinal products and more.
